Health insurance benefits for MSD Korea’s ‘Zepatier’ from this May
‘Zepatier,’ a MSD Korea’s chronic hepatitis C treatment, will be applied for the health insurance system from the 1st of May.
MSD Korea(CEO Avi BenShoshan) announced on the 25th at a press conference that the health insurance benefits will be applied on ‘Zepatier(generic name: elbasvir/grazoprev...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
